Abstract

Citrullination is the conversion of arginine-to-citrulline by protein arginine deiminases (PADs), whose dysregulation is implicated in the pathogenesis of various types of cancers and autoimmune diseases. Consistent with the ability of human cytomegalovirus (HCMV) to induce post-translational modifications of cellular proteins to gain a survival advantage, we show that HCMV infection of primary human fibroblasts triggers PAD-mediated citrullination of several host proteins, and that this activity promotes viral fitness. Citrullinome analysis reveals significant changes in deimination levels of both cellular and viral proteins, with interferon (IFN)-inducible protein IFIT1 being among the most heavily deiminated one. As genetic depletion of IFIT1 strongly enhances HCMV growth, and in vitro IFIT1 citrullination impairs its ability to bind to 5’-ppp-RNA, we propose that viral-induced IFIT1 citrullination is a mechanism of HCMV evasion from host antiviral resistance. Overall, our findings point to a crucial role of citrullination in subverting cellular responses to viral infection.

Citrullination is a posttranslational modification of arginines. Here, the authors show that HCMV infection increases citrullination of host and virus proteins to promote infection and that citrullinated interferon-inducible protein IFIT1 is impaired in RNA binding, as a potential mechanism of evasion.

Details

Title
Human cytomegalovirus-induced host protein citrullination is crucial for viral replication
Author
Griffante Gloria 1 ; Gugliesi Francesca 2   VIAFID ORCID Logo  ; Pasquero Selina 2 ; Dell’Oste Valentina 2   VIAFID ORCID Logo  ; Biolatti Matteo 2   VIAFID ORCID Logo  ; Salinger, Ari J 3 ; Mondal Santanu 4 ; Thompson, Paul R 4   VIAFID ORCID Logo  ; Weerapana Eranthie 5 ; Lebbink Robert J 6 ; Soppe, Jasper A 6 ; Stamminger, Thomas 7 ; Girault Virginie 8   VIAFID ORCID Logo  ; Pichlmair Andreas 8   VIAFID ORCID Logo  ; Oroszlán Gábor 9   VIAFID ORCID Logo  ; Coen, Donald M 9   VIAFID ORCID Logo  ; De, Andrea Marco 10   VIAFID ORCID Logo  ; Landolfo Santo 2   VIAFID ORCID Logo 

 University of Turin, Department of Public Health and Pediatric Sciences, Turin, Italy (GRID:grid.7605.4) (ISNI:0000 0001 2336 6580); University of Piemonte Orientale, Department of Translational Medicine, Novara, Italy (GRID:grid.16563.37) (ISNI:0000000121663741) 
 University of Turin, Department of Public Health and Pediatric Sciences, Turin, Italy (GRID:grid.7605.4) (ISNI:0000 0001 2336 6580) 
 UMass Medical School, Department of Biochemistry and Molecular Pharmacology, Worcester, USA (GRID:grid.168645.8) (ISNI:0000 0001 0742 0364); Boston College, Department of Chemistry, Chestnut Hill, USA (GRID:grid.208226.c) (ISNI:0000 0004 0444 7053) 
 UMass Medical School, Department of Biochemistry and Molecular Pharmacology, Worcester, USA (GRID:grid.168645.8) (ISNI:0000 0001 0742 0364) 
 Boston College, Department of Chemistry, Chestnut Hill, USA (GRID:grid.208226.c) (ISNI:0000 0004 0444 7053) 
 University Medical Center Utrecht, Department of Medical Microbiology, Utrecht, The Netherlands (GRID:grid.7692.a) (ISNI:0000000090126352) 
 Ulm University Medical Center, Institute of Virology, Ulm, Germany (GRID:grid.410712.1) 
 Technical University of Munich, Institute of Virology, Munich, Germany (GRID:grid.6936.a) (ISNI:0000000123222966) 
 Blavatnik Institute, Harvard Medical School, Department of Biological Chemistry & Molecular Pharmacology, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X) 
10  University of Turin, Department of Public Health and Pediatric Sciences, Turin, Italy (GRID:grid.7605.4) (ISNI:0000 0001 2336 6580); University of Piemonte Orientale, CAAD Center for Translational Research on Autoimmune and Allergic Disease, Novara, Italy (GRID:grid.16563.37) (ISNI:0000000121663741) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2544321418
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.